Compounds > 3,4-methylenedioxyamphetamine

3,4-methylenedioxyamphetamine and reboxetine

3,4-methylenedioxyamphetamine has been researched along with reboxetine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brenneisen, R; Grouzmann, E; Hoener, MC; Huwyler, J; Hysek, CM; Ineichen, M; Liechti, ME; Simmler, LD	1

Trials

1 trial(s) available for 3,4-methylenedioxyamphetamine and reboxetine

Article	Year
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clinical pharmacology and therapeutics, 2011, Volume: 90, Issue:2 Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Hallucinogens; Heart Rate; Humans; Male; Morpholines; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Reboxetine; Young Adult	2011

Article

Year

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.

Clinical pharmacology and therapeutics, 2011, Volume: 90, Issue:2

Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Hallucinogens; Heart Rate; Humans; Male; Morpholines; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Reboxetine; Young Adult

2011